The Gynecologic Oncology Program offers gynecologic, gastrointestinal, and urologic surgery for the management of previously untreated gynecologic cancers. These operations include radical hysterectomies for cervical cancer, cytoreductive surgery for ovarian cancer, radical vulvectomies for vulvar cancer and total abdominal hysterectomies, bilateral salpingo-oophorectomies, and lymphadenectomies for the staging and treatment of endometrial cancers. Minimally invasive robotic surgery is also available for some women in need of gynecologic surgery.
Conventional laparoscopic and robotic surgery is available to women in need of surgery for uterine cancer, for removal of the uterus, tubes, and ovaries. The surgeries are also offered to women with invasive cervical cancer who require a radical hysterectomy. Laparoscopic surgery is currently under evaluation for women with ovarian cancer to determine whether optimum upfront surgical cytoreduction is possible, or if neoadjuvant chemotherapy should be used.
When possible, preservation of fertility in women with gynecologic cancers is always a priority. We have routinely preserved fertility in women with rare germ cell ovarian cancers. In addition, we perform radical trachelectomies in women with early stage cervical cancer who desire fertility preservation. For women with early stage, low-grade endometrial cancers, hormonal therapy is prescribed.